Foot-and-mouth disease virus VP1 target the MAVS to inhibit type-I interferon signaling and VP1 E83K mutation results in virus attenuation.

by Pathum Ekanayaka, Seo-Yong Lee, Thilina U B Herath, Jae-Hoon Kim, Tae-Hwan Kim, Hyuncheol Lee, Kiramage Chathuranga, W A Gayan Chathuranga, Jong-Hyeon Park, Jong-Soo Lee
Published 2020-11-01

Scale-Up Production of Type O and A Foot-and-Mouth Disease Bivalent Vaccine and Its Protective Efficacy in Pigs

by Sang-Hyun Park, Seo-Yong Lee, Jae-Seok Kim, Ah-Young Kim, Sun-Young Park, Ji-Hye Lee, Mijung Lee, Hyejin Kim, Sim-In Lee, Na-Young Kang, Jung-Won Park, Su-Mi Kim, Jong-Hyeon Park, Young-Joon Ko
Published 2021-06-01